Lineage Cell Therapeutics, Inc. Common Stock (LCTX) Long-Term Debt & History | Stock Alarm

Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock · Long-Term Debt

LCTX Long-Term Debt

Latest reported$1.57Mperiod endingDec 31, 2025

LCTX FY Long-Term Debt ($0.00 → $1.57M)

Annual long-term debt

High-resolution chart · PNG

LCTX long-term debt history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Long-Term Debt — Annual fiscal periods (USD)
Period ending	Long-Term Debt (USD)
Dec 31, 2025	1,566,000
Dec 31, 2024	1,362,000
Dec 31, 2023	2,070,000
Dec 31, 2022	2,944,000
Dec 31, 2021	1,971,000
Dec 31, 2020	2,540,000
Dec 31, 2019	3,945,000
Dec 31, 2018	1,958,000
Dec 31, 2017	1,169,000
Dec 31, 2016	2,848,000
Dec 31, 2015	4,970,000
Dec 31, 2014	469,000
Dec 31, 2013	0
Dec 31, 2012	0
Dec 31, 2011	0
Dec 31, 2010	0
Dec 31, 2009	0
Dec 31, 2008	0
Dec 31, 2007	0
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	2,168,804
Dec 31, 2001	1,731,122
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Jun 30, 1998	0
Jun 30, 1996	0
Jun 30, 1995	0
Jun 30, 1994	0
Jun 30, 1993	0
Jun 30, 1992	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.